CHRS Competitors
Coherus Oncology, Inc.
$1.01
$0.00(0.00%)
--
Overall
--
Value
--
Tech
--
Quality
Market Cap
--
Volume
30.05K
52W Range
$0.97 - $2.62
Target Price
--
CHRS competitors: ACOR, ARNA, AMGN, RGEN. Coherus Oncology, Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
CHRS Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| AMGN Amgen Inc. | $444.63 | $241.81B | $22.94 | 2.24% | 73 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CHRS | $1.01 | 0% | 30.05K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |